Literature DB >> 2998034

Residual transforming activity of PY1178T, a mutant lacking the principal in vitro tyrosine phosphorylation site, is not affected by removal of the secondary tyrosine phosphorylation site at residue 322.

B S Schaffhausen, T J Liang, G G Carmichael, T L Benjamin.   

Abstract

Polyoma virus mutants lacking one or both tyrosines at position 315 and 322 of wild-type middle T antigen have been constructed. The effects of the removal of these tyrosines are additive for middle T phosphorylation in immune complexes, with tyrosine 315 being the major acceptor site and 322 a secondary site. Previous studies have shown little or no effect of deletion of tyrosine 322 on transforming ability, whereas a strong effect has been seen by substitution of phenylalanine for tyrosine 315. In contrast to the phosphokinase results, there is no additive effect of combining these mutations on the viruses' transforming ability. Thus the double mutant lacking both tyrosines has the same weak transforming activity as the single mutant containing tyrosine 322 and phenylalanine 315. Phosphorylation of middle T antigen at tyrosine 322 by pp60c-src or other tyrosine-specific cellular protein kinase is therefore unimportant for transformation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2998034     DOI: 10.1016/0042-6822(85)90410-6

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  10 in total

Review 1.  Natural biology of polyomavirus middle T antigen.

Authors:  K A Gottlieb; L P Villarreal
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

2.  Interactions of polyomavirus middle T with the SH2 domains of the pp85 subunit of phosphatidylinositol-3-kinase.

Authors:  M Yoakim; W Hou; Y Liu; C L Carpenter; R Kapeller; B S Schaffhausen
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

3.  12-O-tetradecanoylphorbol-13-acetate stimulates phosphorylation of the 58,000-Mr form of polyomavirus middle T antigen in vivo: implications for a possible role of protein kinase C in middle T function.

Authors:  J T Matthews; T L Benjamin
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

Review 4.  Lessons in signaling and tumorigenesis from polyomavirus middle T antigen.

Authors:  Michele M Fluck; Brian S Schaffhausen
Journal:  Microbiol Mol Biol Rev       Date:  2009-09       Impact factor: 11.056

5.  A completely transformation-defective point mutant of polyomavirus middle T antigen which retains full associated phosphatidylinositol kinase activity.

Authors:  B J Druker; L E Ling; B Cohen; T M Roberts; B S Schaffhausen
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

6.  A Transformation-Defective Polyomavirus Middle T Antigen with a Novel Defect in PI3 Kinase Signaling.

Authors:  Deborah Denis; Cecile Rouleau; Brian S Schaffhausen
Journal:  J Virol       Date:  2017-01-03       Impact factor: 5.103

7.  Phosphatidylinositol metabolism and polyoma-mediated transformation.

Authors:  D R Kaplan; M Whitman; B Schaffhausen; L Raptis; R L Garcea; D Pallas; T M Roberts; L Cantley
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

8.  Polyomavirus middle T antigen induces ribosomal protein S6 phosphorylation through pp60c-src-dependent and -independent pathways.

Authors:  D A Talmage; J Blenis; T L Benjamin
Journal:  Mol Cell Biol       Date:  1988-06       Impact factor: 4.272

9.  Catalytically inactive protein phosphatase 2A can bind to polyomavirus middle tumor antigen and support complex formation with pp60(c-src).

Authors:  E Ogris; I Mudrak; E Mak; D Gibson; D C Pallas
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

10.  Identification of TAZ as a binding partner of the polyomavirus T antigens.

Authors:  Yu Tian; Dawei Li; Jean Dahl; John You; Thomas Benjamin
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.